施雄伟

Executive VP， Ph.D. in Synthetic Organic Chemistry from State University of New York and postdoc at Cornell University. 9 years in Schering-Plough as a Principal Scientist on development projects to support phase I， II， III studies and commercial production of intermediates and APIs， including new synthesis and process development of drug candidates for Alzheimer’s disease （M2）， Parkinson’s disease （AdA2） and AIDS disease （CCR5）， anti-fungal and anticancer （FPTI） in cGMP environments. Published more than 20 papers in international journals and holds many patents. Founder of United PharmaTech Company， which merged with Sundia in 2007.